MRSA

Ultraviolet light - an invisible weapon against MRSA

A few years ago, Dr Peder Bo Nielsen MD FRCPath, Consultant medical microbiologist at Northwick Park Hospital, London, UK, launched a research programme on airborne transmission of nosocomial infections. Until then, so called air-biology held no high priority in infection prevention and control. The prevailing perception was that colonisation and contamination mainly happens due to direct contact…

Photo

Article • MRSA

Effective screening can kill several birds with one stone

The MRSA problem has been ignored almost stoically in many European countries for the past 20 years. Thus the number of resistant Staphylococci cases exploded from 1% in 1990 around 25% in 2010. However, the recognition that an infection can result in additional hospital costs of up to €10,000 has led to a change in thinking. The Netherlands, for example, declared war on MRSA with ‘search and…

Photo

Article • Enzyme extended-spectrum beta-lactimase

ESBL: A greater danger than MRSA?

In hospitals, MRSA is considered Public Enemy Nr 1, and the increase in nosocomial infections, worldwide, has drawn universal attention to this ‘superbug’. However, Staphylococcus aureus is not alone – other pathogens are proving their resistance to antibiotics, in the last decade, gram-negative enterobacteria, which form the enzyme extended-spectrum beta-lactimases (ESBL), have joined the…

Photo

New weapons enter the un-ending war against MRSA

A decade ago the battle against hospital-acquired MRSA (methicillin-resistant Staphylococcus aureus bacterial strain) infections appeared to be lost, or at least without end. However, today, we see very important science-to-business achievements in this field. Report: Rostislav Kuklik

Infection outbreaks to be published weekly

A change in political control naturally creates change in the way things are run, and the jaw-jutting ‘Get tough’ nature of the UK’s new coalition Government is palpable. For hospitals, one early change relates to data reporting on MRSA bloodstream infections and C. Difficile. Up to now, these were published monthly by the National Health Service (NHS) Trust; soon they will be published…

Photo

MRSA - Keeping up with the neighbours

The border between Germany and the Netherlands in the so-called EUREGIO region is of no particular importance in the daily life of the people who live there. Every day, thousands commute between towns and cities in both countries, to work, shop or even receive medical treatment. The latter, however, presents Dutch hospitals with a problem.

Photo

Surgical site infections

Post-operative wound infection occurs after an estimated 17% of surgical operations – sometimes with devastating consequences for the patient. The list of preventive measures is manifold and long. However, one strategy is increasingly moving into the spotlight: the use of antibacterial coated sutures. Ethicon Products is at the cutting edge in this field. Sandra Rasche, head of this Business…

Photo

Pneumonia research in Spain

In November 2009 about 150 leading infectious disease researchers gathered in Berlin for the National Forum for Innovation in Medicine. During the meeting, Professor Antoni Torres MD (Hospital Clinic-Ciberes, University of Barcelona) gave Meike Lerner insights into community acquired pneumonia research projects and findings

Photo

Germany legislates for MRSA reporting

The UK, Denmark, Ireland, Sweden and the Netherlands already have it - an official obligation to report MRSA cases to their health authorities. Since 1 July 2009 German law has also required notification. Professor Herbert Hof, Director of the Institute for Microbiology and Hygiene at the University Hospital Mannheim, Germany, explained why such notification became essential.

Photo

LightCycler MRSA Advanced Test cheats time

How the PCR-Test works The MRSA bacterium contains an additional 'mobile gene cassette' (SCCmec cassette) in its genetic makeup, which contains the so-called mecA gene. All beta-Lactam antibiotics such as Methicillin are therefore no longer effective. The LightCycler MRSA Advanced Test facilitates the detection of all five known SCCmec types within 85 to 100 minutes. This test principle is based…

Positive action in the war against MRSA

The first strain of methicillin resistant Staphylococcus Aureus (MRSA) was isolated in the 1960s, and its presence was reported worldwide in the late 1990s. A higher incidence of MRSA was noted in communities, at the dawn of the new millennium, leading to two basic MRSA strains being differentiated - CA-MRSA (community acquired MRSA) and HA-MRSA (healthcare associated MRSA). In clinical practice…

Photo

Nosocomial infections

According to ECD statistics for Europe, three million cases of nosocomial infections occur annually, and 50,000 are fatal. Evelina Tacconelli MD PhD (below) is Assistant Professor of Infectious Diseases at the Università Cattolica Sacro Cuore in Rome, Italy. Her scientific focus is on epidemiology, clinical and therapeutic aspects of nosocomial infections and infection control policies aimed to…

Photo

Copper fittings beat bacteria

Following an international field trial of "Antimicrobial copper surfaces", Asklepios Clinic, in Hamburg, Germany, has fitted door handles and light switches made of special copper alloys combat the spread of antibiotic-resistant bacteria.

Faster, More Affordable Test Being Developed for Improved MRSA Screening

A rapid, portable, point-of-care test for Methicillin-resistant Staphylococcus aureus (MRSA), developed by TwistDx based on a new way of detecting DNA, was one of nine products chosen from approximately 250 applications submitted to the Smart Solutions for HCAI programme, an NHS project that aims to identify innovative technologies with the potential to fight hospital bugs.

Photo

Decreasing MRSA infections in UK

MRSA bloodstream infections in England are continuing to fall, the latest quarterly statistics from the Health Protection Agency (HPA) showed: There were 725 MRSA bloodstream infections in England between July and September. This represents a 13% decrease on the previous quarter (April to June) when there were 837 cases and a 33% reduction in the corresponding quarter of 2007.

Photo

BioCote reduces bacteria by 95% in hospitals

The antimicrobial technology firm BioCote Ltd, which is showing its products at the British Pavillion, is also promoting the results from the first study to investigate how silver antimicrobial products can reduce levels of bacteria in hospitals, clinics and care homes.

Photo

New ingredient in paints kills superbugs

Scientists found out that particles of titanium dioxide, which is e.g. contained in the white lines at tennis courts, can kill bacteria and destroy dirt when activated by fluorescent light. Added in paints, the nanotitanium can kill superbugs on all surfaces in hospitals.

22 show more articles
Subscribe to Newsletter